Published Date: 08 Mar 2023
When grandpa Izzy Mokotoff stopped writing his weekly newsletter in the spring of 2022, he knew he had to find a solution. Parkinson's disease was slowly destroying my grandfather's central nervous system.
Read Full NewsWithin the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
1.
Novel Agent Effective for Cancer Wasting Disorder
2.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
3.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
4.
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
5.
Scientists call into question safety of potential new anticancer treatment
1.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
2.
Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits
3.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
4.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
5.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation